Cite

Figure 1

Study flow chart AR = Allergic rhinitis, CXR = chest x-ray, PNS = film paranasal sinus, FEV1 = force expiratory volume in 1 s.
Study flow chart AR = Allergic rhinitis, CXR = chest x-ray, PNS = film paranasal sinus, FEV1 = force expiratory volume in 1 s.

Prevalence of abnormal pulmonary function (Force expiratory volume in 1 s <80%), duration of allergy, severity of allergic symptoms, and sensitization to allergens

Number Prevalence (%)
Overall prevalence 153 23 (15)
Duration of allergy
 ≤ 5 years 62 10 (16)
 5-10 years 52 7 (14)
 ≥ 10 years 39 6 (15)
Severity of allergic symptoms
 Mild intermittent 38 4 (11)
 Moderate/severe intermittent 37 5 (14)
 Mild persistent 19 2 (11)
 Moderate/severe persistent 59 12 (20)
Sensitization to indoor allergens 25 1 (4)
Sensitization to outdoor allergens 16 1 (6)
Sensitization to both indoor and outdoor allergens 112 21 (19)

Clinical characteristics and their relation to percent changes of FEV1

Characteristics Total Subject with percent change FEV1≥ 12% OR 95%CI P
Duration of allergy (y)
 ≤ 5 62 0 (0%) - -
 5-10 52 3 (5.8%) - - 0.06
 ≥ 10 39 1 (2.6%) - - 0.21
Severity of allergic symptoms
 Mild intermittent 38 1 (2.63%) 1 -
 Moderate/severe intermittent 37 1 (2.7%) 1.03 0.07-15.82 0.99
 Mild persistent 19 0 (0%) 0 - 0.48
 Moderate/severe persistent 59 2 (3.39%) 1.28 0.12-13.71 0.83
Sensitization to indoor allergens 25 2 (8%) 5.12 0.75-34.66 0.06
Sensitization to outdoor allergens 16 0 (0%) 0 0 0.48
Sensitization to indoor and outdoor allergens 112 2 (1.79%) 0.36 0.05-2.51 0.28

Clinical characteristics and their relation to FEV1

Characteristics Total Subject with FEV1 < 80% OR 95%CI P
Duration of allergy (y)
 ≤ 5 62 10 (16%) 1 -
 5-10 52 7 (14%) 0.83 0.34-2.04 0.691
 ≥ 10 39 6 (15%) 0.95 0.38-2.42 0.921
Severity of allergic symptoms -
 Mild intermittent 38 4 (11%) 1 -
 Moderate/severe intermittent 37 5 (14%) 1.28 0.37-4.41 0.691
 Mild persistent 19 2 (11%) 1 0.20-4.98 1.000
 Moderate/severe persistent 59 12 (20%) 1.93 0.67-5.55 0.203
Sensitization to indoor allergens 59 1 (4%) 0.23 0.08-1.65 0.09
Sensitization to outdoor allergens 16 1 (6%) 0.39 0.06-2.69 0.29
Sensitization to indoor and outdoor allergens 112 21 (19%) 7.79 1.08-55.91

P < 0.05

0.03

Clinical characteristics and their relation to FEF25–75

Characteristics Total Participant with FEF2–75<80% OR 95%CI P
Duration of allergy (y)
 ≤ 5 62 10 (16%) 1 -
 5-10 52 14 (27%) 1.67 0.81-3.04 0.16
 ≥ 10 39 13 (33%) 2.07 1.01-4.25

P < 0.05

0.04
Severity of allergic symptoms
 Mild intermittent 38 10 (26%) 1 -
 Moderate/severe intermittent 37 9 (24%) 0.92 0.42-2.01 0.04
 Mild persistent 19 4 (21%) 0.80 0.28-2.21 0.66
 Moderate/severe persistent 59 14 (24%) 0.90 0.44-1.81 0.77
Sensitization to indoor allergens 25 8 (32%) 1.41 0.73-2.71 0.31
Sensitization to outdoor allergens 16 6 (38%) 1.66 0.82-3.35 0.19
Sensitization to both indoor and outdoor allergens 112 23 (21%) 0.60 0.34-1.05 0.08

Prevalence of abnormal pulmonary function test results

Number (percent)
Abnormal FEV1 23 (15%)
Abnormal % change of FEV1 4 (3%)
Abnormal FEF25–75 37 (24%)

Patient characteristics

Characteristics Number (percent)
Age (years)
 Mean ± standard deviation 34.4 ±10.5 (range 20-59)
Sex
 Male/Female 46 (30%)/107 (70%)
Duration of symptoms
 ≤ 5 years 62 (41%)
 5-10 years 52 (34%)
 ≥ 10 years 39 (26%)
Severity of allergic rhinitis
 Mild intermittent 38 (25%)
 Moderate/severe intermittent 37 (24%)
 Mild persistent 19 (12%)
 Moderate/severe persistent 59 (39%)
Allergic to indoor allergens 25 (16%)
Allergic to outdoors allergens 16 (11%)
Allergic to both indoor and outdoor allergens 112 (73%)
eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine